Project Grant HT94252410107
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$119K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Israel
Similar Awards
The U.S. Defense Health Agency awarded a $388,060 Project Grant to the Hebrew University of Jerusalem's Authority for Research and Development Division under the Department of Defense's Military Medical Research and Development program (CFDA 12.420). The 2-year grant, which runs from September 30, 2023 to September 29, 2025, will fund epigenetic liquid biopsy research for Duchenne and Becker muscular dystrophy. The Hebrew University, a leading academic institution in Israel, will conduct the...
The Defense Health Agency awarded a $293,500 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Medical Research, Infrastructure And Health Services Fund Of The Tel Aviv Medical Center, a non-profit research organization located in Israel. The grant, effective from April 1, 2025 to March 31, 2027, will fund a research project investigating clinical variations in epidermolysis bullosa, a rare genetic skin condition, with the goal of...
The Weizmann Institute of Science received a $896,775 project grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 through June 2024 to uncover the coevolution of the microenvironment in breast cancer metastasis, with the goal of discovering novel therapeutic targets. Through basic, applied, and advanced biomedical research support, the Military Medical Research and...
The federal Project Grant award of $1,214,375.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), is funding a research project led by Yale University. The project is investigating the use of decoy-resistant IL-18 and immune checkpoint inhibitors in preclinical murine and ex vivo patient-derived models of renal cell carcinoma. The award began on September 15, 2024 and is set to conclude on September 14, 2028. The Military Medical Research...
The Department of Defense (DoD) has awarded a $846,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Institute For Cancer Research, a non-profit research organization, to investigate PALB2 mutant breast cancer. The funding supports a 3-year research project from August 1, 2024 to July 31, 2027. As the prime grantee, The Institute For Cancer Research will conduct innovative scientific studies and clinical trials focused on developing new treatments...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $889,995.00 Project Grant to the Dana-Farber Cancer Institute, Inc. (dba Dfci), a non-profit hospital and cancer research center in Boston, MA. The grant, effective June 1, 2024 through May 31, 2027, supports research to "dissect the interplay of molecular and spatial architectures with clinical states in prostate cancer." This federal funding will enable Dana-Farber to conduct...
The Defense Health Agency awarded a $784,602 Project Grant to Dana-Farber Cancer Institute, Inc. (doing business as Dfci) under the Military Medical Research and Development program (CFDA 12.420). The grant will support research from January 2023 to January 2026 to develop next-generation immunotherapy for breast cancer by turning breast cancer cells against themselves. The Military Medical Research and Development program aims to transform military and public health through innovative medical...
The Department of Defense (DoD) awarded a $166,487.49 Project Grant to the Weizmann Institute of Science in Israel under the Basic Scientific Research program (CFDA 12.431) to support the development of an autonomous cell-free ribosome biogenesis system reconstituted on a photonic chip. This research project, which has a performance period from March 1, 2025 to February 29, 2028, is aimed at advancing fundamental knowledge in areas such as quantum computing, artificial intelligence, and...
The federal Project Grant award, valued at $2,685,519.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research at Cedars-Sinai Medical Center in West Hollywood, California to define human correlates of super-evasive disseminated tumor cells, assess their pathological relevance, and develop methods to eradicate them. The research project, which runs from July 1, 2025 to June 30, 2029, aims to transform...
The U.S. Department of Defense's Defense Health Agency awarded a $1,882,607 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to The University of Texas MD Anderson Cancer Center. The grant, titled "LEVERAGING PROSTATE CANCERS' UNIQUE LIPID METABOLISM TO INDUCE THERAPEUTIC FERROPTOSIS," will fund advanced biomedical research focused on transforming healthcare for military service members and the broader public. The research aims to investigate...